The purpose of this study is to test the effectiveness of the Canary Breathing System (CBS) in treating the symptoms of panic disorder.
Panic disorder (PD) is associated with hyperventilation. The efficacy of a brief respiratory feedback program for PD has been previously established. The aim of the present study was to expand these results by testing a similar program with more clinically representative patients and settings. The intervention is delivered via home use following initial training by a clinician and provides remote monitoring of client adherence and progress by the clinician. Outcomes were assessed post-treatment and at 2- and 12-month follow-up.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
69
The Canary Breathing System is a biofeedback device meant to assist patients in the re-training of abnormal breathing patterns.
San Francisco Bay Area Center for Cognitive Therapy
Oakland, California, United States
Institute of Living
Hartford, Connecticut, United States
Alexian Brothers Center for Anxiety and OCD
Hoffman Estates, Illinois, United States
Kansas City Center for Anxiety Treatment, P.A.
Overland Park, Kansas, United States
Percent of Subjects Achieving a 40% Decrease in Overall PDSS Score (Clinically Significant Response)
The Panic Disorder Severity Scale (PDSS) (Shear, 1997) is a widely used assessment tool measuring panic disorder symptom severity and impact. Seven questions are scored from 0 to 4 giving minimum and maximum scores of zero and 28 respectively. Higher scores represent more severe impact of symptoms. A 40% decrease has been reported to be clinically significant (Furukawa et al 2009) and is defined as "Response" in this study.
Time frame: Measured at 2 months post-treatment.
Percent of Subjects Achieving a 40% Decrease in Overall PDSS Score (Clinically Significant Response)
The Panic Disorder Severity Scale (PDSS) (Shear, 1997) is a widely used assessment tool measuring panic disorder symptom severity and impact. Seven questions are scored from 0 to 4 giving minimum and maximum scores of zero and 28 respectively. Higher scores represent more severe impact of symptoms. A 40% decrease has been reported to be clinically significant (Furukawa et al 2009) and is defined as "Response" in this study.
Time frame: Measured post-treatment (week-5)
Percent of Subjects Achieving a 40% Decrease in Overall PDSS Score (Clinically Significant Response)
The Panic Disorder Severity Scale (PDSS) (Shear, 1997) is a widely used assessment tool measuring panic disorder symptom severity and impact. Seven questions are scored from 0 to 4 giving minimum and maximum scores of zero and 28 respectively. Higher scores represent more severe impact of symptoms. A 40% decrease has been reported to be clinically significant (Furukawa et al 2009) and is defined as "Response" in this study.
Time frame: Measured at 12 months post-treatment.
Percent of Subjects Achieving Zero Panic Attacks Reported in Previous Week
Time frame: Measured post-treatment (week-5)
Percent of Subjects Achieving Zero Panic Attacks Reported in Previous Week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Measured at 2 months post-treatment
Percent of Subjects Achieving Zero Panic Attacks Reported in Previous Week
Time frame: Measured at 12 months post-treatment